Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Cancer vaccines: Harnessing the potential of anti-tumor immunity
Mark A. Suckow
Administration (AHS)
Research output
:
Contribution to journal
›
Review article
›
peer-review
16
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cancer vaccines: Harnessing the potential of anti-tumor immunity'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Tumor
100%
Cancer Vaccine
100%
Tumor Immunity
100%
Immune System
80%
Tumor Antigen
80%
Anti-tumor Response
40%
Nucleic Acids
20%
Clinical Application
20%
Tumor Growth
20%
Tumor Cells
20%
Veterinary
20%
Extracellular Matrix
20%
Immunization
20%
Interleukin-2
20%
Glycoprotein
20%
Recombinant Protein
20%
Selective Pressure
20%
Canine Oral Melanoma
20%
Vaccine Adjuvant
20%
Significant Benefit
20%
Metastasizing
20%
Tyrosinase
20%
Melanin Synthesis
20%
Tumor Stroma
20%
Tumor Survival
20%
Tumor Immunology
20%
Antigen Targeting
20%
Tumor Cell Subpopulations
20%
Dividends
20%
Immune Destruction
20%
Immunoediting
20%
Evade
20%
Immunostimulatory Molecules
20%
Immunology and Microbiology
Tumor Immunity
100%
Tumor Vaccine
100%
Tumor Antigen
100%
Immune System
100%
Tumor Cell
50%
Stroma
50%
Glycoprotein
25%
Tumor Immunology
25%
Vaccine Adjuvant
25%
Interleukin 2
25%
Cell Population
25%
Melanogenesis
25%
Immunoediting
25%
Extracellular Matrix
25%